Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU

Anticancer Research

Volumn 25, Issue 2 B, 2005, Pages 1377-1384

  Takahashi, Yutaka ^a   Mai, Masayoshi ^a   Nakazato, Hiroaki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b Yokoyama Gastrointestinal Hospital   (Japan)

Author keywords

5 fluorouracil; CEA; Immunochemotherapy; PPD; PSK

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; KRESTIN; TUBERCULIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; IMMUNOCOMPETENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZATION;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEOGLYCANS; SURVIVAL RATE; TUBERCULIN;

EID: 17444412319     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Click JH, Veeder MH and Mailliard JA: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358, 1990.
2. th ASCO Meeting Educational Book 228-239, 2002.
3. Nakazato H, Koike A, Saji S, Ogawa N and Sakamoto J: Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343: 1122-1126, 1994.
4. Nakajima T, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondou T, Abe O, Kikuchi K, Tanabe T and Ogawa N: Multi-institutional cooperative study of adjuvant immunochemotherapy for gastric cancer: five-year survival rate. Jpn J Cancer Chemother 16: 799-806, 1989.
5. Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, Nakamura S, Kakinuma S, Iwazaki S, Ishikawa H, Kawate S, Nakajima T and Morishita Y: Adjuvant immunochemotherapy with oral tegafur/uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer 90: 1003-1010, 2004.
6. Mitomi T, Tsuchiya S, Iilima N, Aso K, Nishiyama K, Amano T, Takahashi T, Oka H, Murayama N, Oya K, Noto T and Ogawa N: Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer: 5 year follow-up after surgery (a final report). J Jpn Soc Cancer Ther 28: 71-83, 1993.
7. Ito K, Nakazato H, Koike A, Takagi H, Saji S, Baba S, Mai M, Sakamoto J and Ohashi Y: Int J Colorectal Dis 19: 157-164, 2004.
8. Konno K, Motomiya M, Oizumi K, Sato M, Yamamoto F, Tamiya K, Hasuike T, Yokosaea A, Uchiyama T, Ogawa N and Nakai Y: Effects of protein-bound polysaccharide preparation (PSK) in small cell carcinoma of the lung. Haigan 28: 19-28, 1988.
9. Munemoto Y, Iida Y, Abe J, Saito H, Fujisawa K, Kasahara Y, Mitsui T, Asada Y and Miura S: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: association between host or tumor factors and survival. Int J Oncol 20: 403-411, 2002.
10. Medoff JR, Jegasothy BV and Roche JK: Carcinoembryonic antigen-induced release of a suppressor factor from normal human lymphocytes in vitro. Cancer Res 44: 5822-5827, 1984.
11. Medoff JR, Clack VC and Roche JK: Characterization of an immunosuppressive factor from malignant ascites that resembles a factor induced in vitro by carcinoembryonic antigen. J Immunol 137: 2057-2064, 1986.
12. Nio Y, Tamura K, Masai Y, Hayashi H, Araya S, Imai S, Shiraishi T, Tseng CC, Kawabata K, Tsuboi K, Tsubono M, Sato M and Imamura M: Multi-institutional study on the immunomodulatory effect of protein-bound polysaccharide, PSK on the immunity of patients after gastric and colorectal cancer surgery. J Jpn Soc Cancer Ther 30: 1623-1634, 1995.
13. Hayashibe A, Tanaka H, Kitoh H, Sakamoto K, Taruya E, Nakaue K, Yanagi Z, Tokura K, Asada K and Takebayashi J: Pre- and postoperative investigation on immunoactivity of the patients with gastric cancer: with a special reference to the effect of PSK. J Jpn Soc Cancer Ther 29: 647-653, 1994.
14. Vyakarnam A and Lachmann PJ: Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells. Immunol 53: 601-610, 1984.
15. Tamada R, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Abe O, Kikuchi K, Tanabe T, Nakajima T and Ogawa N: A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II). Gan To Kagaku Ryoho 14: 716-722, 1987.